The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Methyl N'-(3-(4-Chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazol-1-yl)(((4-(trifluoromethyl)phenyl)sulfonyl)imino)-methyl)carbamimidothioate ID: ALA4103562
PubChem CID: 137657468
Max Phase: Preclinical
Molecular Formula: C25H21ClF3N5O2S2
Molecular Weight: 580.06
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CS/C(N)=N\C(=N/S(=O)(=O)c1ccc(C(F)(F)F)cc1)N1CC(c2ccccc2)C(c2ccc(Cl)cc2)=N1
Standard InChI: InChI=1S/C25H21ClF3N5O2S2/c1-37-23(30)31-24(33-38(35,36)20-13-9-18(10-14-20)25(27,28)29)34-15-21(16-5-3-2-4-6-16)22(32-34)17-7-11-19(26)12-8-17/h2-14,21H,15H2,1H3,(H2,30,31,33)
Standard InChI Key: FTGCSCGERPAADR-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 41 0 0 0 0 0 0 0 0999 V2000
16.1210 -7.6890 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.3356 -6.9007 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
15.5456 -7.1090 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.8717 -4.4350 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.5517 -4.8882 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.1941 -4.3830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9098 -3.6141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0943 -3.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5837 -5.7048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8926 -6.1409 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.3069 -6.0853 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.1694 -5.7603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4783 -6.1964 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.0622 -7.2824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0912 -8.0982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8136 -8.4786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5057 -8.0425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4709 -7.2218 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7481 -6.8451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5902 -3.0105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8935 -2.2505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3873 -1.6099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5778 -1.7281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2771 -2.4925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7852 -3.1299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3587 -2.9364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1753 -2.9891 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6273 -2.3092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2640 -1.5763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4440 -1.5274 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9956 -2.2080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0700 -1.0878 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
14.1373 -4.9438 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
13.4141 -4.5633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2294 -8.4221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2626 -9.2386 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
19.9200 -7.9851 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
19.9345 -8.8281 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 4 2 0
5 9 1 0
9 10 1 0
9 11 2 0
10 12 2 0
12 13 1 0
11 2 1 0
2 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
8 20 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 26 1 0
7 26 1 0
23 32 1 0
12 33 1 0
33 34 1 0
17 35 1 0
35 36 1 0
35 37 1 0
35 38 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 580.06Molecular Weight (Monoisotopic): 579.0777AlogP: 5.58#Rotatable Bonds: 4Polar Surface Area: 100.48Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 5.69CX LogP: 6.15CX LogD: 6.14Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.32Np Likeness Score: -1.11
References 1. Iyer MR, Cinar R, Katz A, Gao M, Erdelyi K, Jourdan T, Coffey NJ, Pacher P, Kunos G.. (2017) Design, Synthesis, and Biological Evaluation of Novel, Non-Brain-Penetrant, Hybrid Cannabinoid CB1R Inverse Agonist/Inducible Nitric Oxide Synthase (iNOS) Inhibitors for the Treatment of Liver Fibrosis., 60 (3): [PMID:28085283 ] [10.1021/acs.jmedchem.6b01504 ]